Metabolomic Analyses to Identify Candidate Biomarkers of Cystinosis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032603 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Emirhan Nemutlu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Analytical Chemistry, Hacettepe University, Sihhiye, Ankara 06100, Türkiye. Hauptthemen laut MEDLINE: Cystinosis, Amino Acid Transport Systems, Neutral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Turkey, The Scientific and Technological Research Council of Türkiye (TÜBİTAK).
Abstract (Originalsprache)
Cystinosis is a rare, devastating hereditary disease secondary to recessive CTNS gene mutations. The most commonly used diagnostic method is confirmation of an elevated leukocyte cystine level; however, this method is expensive and difficult to perform. This study aimed to identify candidate biomarkers for the diagnosis and follow-up of cystinosis based on multiomics studies. The study included three groups: newly-diagnosed cystinosis patients (patient group, n = 14); cystinosis patients under treatment (treatment group, n = 19); and healthy controls (control group, n = 30). Plasma metabolomics analysis identified 10 metabolites as candidate biomarkers that differed between the patient and control groups [L-serine, taurine, lyxose, 4-trimethylammoniobutanoic acid, orotic acid, glutathione, PE(O-18:1(9Z)/0:0), 2-hydroxyphenyl acetic acid, acetyl-N-formil-5-metoxikinuramine, 3-indoxyl sulphate]. As compared to the healthy control group, in the treatment group, hypotaurine, phosphatidylethanolamine, N-acetyl-d-mannosamine, 3-indolacetic acid, p-cresol, phenylethylamine, 5-aminovaleric acid, glycine, creatinine, and saccharic acid levels were significantly higher, and the metabolites quinic acid, capric acid, lenticin, xanthotoxin, glucose-6-phosphate, taurine, uric acid, glyceric acid, alpha-D-glucosamine phosphate, and serine levels were significantly lower. Urinary metabolomic analysis clearly differentiated the patient group from the control group by means of higher allo-inositol, talose, glucose, 2-hydroxybutiric acid, cystine, pyruvic acid, valine, and phenylalanine levels, and lower metabolite (N-acetyl-L-glutamic acid, 3-aminopropionitrile, ribitol, hydroquinone, glucuronic acid, 3-phosphoglycerate, xanthine, creatinine, and 5-aminovaleric acid) levels in the patient group. Urine metabolites were also found to be significantly different in the treatment group than in the control group. Thus, this study identified candidate biomarkers that could be used for the diagnosis and follow-up of cystinosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Analytical Chemistry, Hacettepe University, Sihhiye, Ankara 06100, Türkiye.
- Department of Pediatric Nephrology, Hacettepe University School of Medicine, Sihhiye, Ankara 06100, Türkiye.
- Nephrogenetics Laboratory, Department of Pediatric Nephrology, Hacettepe University School of Medicine, Sihhiye, Ankara 06100, Türkiye.
- Faculty of Pharmacy, Department of Biochemistry, Hacettepe University, Sihhiye, Ankara 06100, Türkiye.
- Vocational School of Health Services, Hacettepe University, Ankara 06100, Türkiye.
- Faculty of Pharmacy, Department of Analytical Chemistry, Lokman Hekim University, Sogutozu, Ankara 06510, Türkiye.
ORCID-Profile: Emirhan Nemutlu, Fatih Ozaltin, Cemil Can Eylem, İpek Baysal, Elif Damla Gök-Topak, Gulberk Ucar
Förderung
- Scientific and Technological Research Council of Turkey
- The Scientific and Technological Research Council of Türkiye (TÜBİTAK)
Zitieren
APA
Nemutlu, E., Ozaltin, F., Yabanoglu-Ciftci, S., Gulhan, B., Eylem, C. C., Baysal, İ., Gök-Topak, E. D., Ulubayram, K., Sezerman, O. U., Ucar, G., Kır, S., & Topaloglu, R. (2023). Metabolomic Analyses to Identify Candidate Biomarkers of Cystinosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032603
Vancouver
Nemutlu E, Ozaltin F, Yabanoglu-Ciftci S, Gulhan B, Eylem CC, Baysal İ, et al. Metabolomic Analyses to Identify Candidate Biomarkers of Cystinosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032603
BibTeX
@article{Nemutlu2023,
author = {Nemutlu, Emirhan and Ozaltin, Fatih and Yabanoglu-Ciftci, Samiye and Gulhan, Bora and Eylem, Cemil Can and Baysal, İpek and Gök-Topak, Elif Damla and Ulubayram, Kezban and Sezerman, Osman Ugur and Ucar, Gulberk and Kır, Sedef and Topaloglu, Rezan},
title = {Metabolomic Analyses to Identify Candidate Biomarkers of Cystinosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032603}
}
EUVIMED